NDC 0054-0479

Dalfampridine

Dalfampridine

Dalfampridine is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceuticals Corp.. The primary component is Dalfampridine.

Product ID0054-0479_0dd1f0f1-c865-4a18-933e-d63919f21528
NDC0054-0479
Product TypeHuman Prescription Drug
Proprietary NameDalfampridine
Generic NameDalfampridine
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2020-07-13
Marketing CategoryANDA / ANDA
Application NumberANDA206646
Labeler NameWest-Ward Pharmaceuticals Corp.
Substance NameDALFAMPRIDINE
Active Ingredient Strength10 mg/1
Pharm ClassesPotassium Channel Blocker [EPC],Potassium Channel Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0054-0479-21

60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0054-0479-21)
Marketing Start Date2020-07-13
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Dalfampridine" or generic name "Dalfampridine"

NDCBrand NameGeneric Name
0054-0479DalfampridineDalfampridine
0378-0509dalfampridinedalfampridine
0378-4504dalfampridinedalfampridine
0591-2533DalfampridineDalfampridine
16729-292DalfampridineDalfampridine
42571-275DALFAMPRIDINEDALFAMPRIDINE
51407-246DalfampridineDalfampridine
62756-429DalfampridineDalfampridine
63629-9450DalfampridineDalfampridine
65862-863DALFAMPRIDINEDALFAMPRIDINE
67877-444DalfampridineDalfampridine
10144-427AMPYRADalfampridine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.